메뉴 건너뛰기




Volumn 7, Issue 2, 2012, Pages

Nilotinib and imatinib are comparably effective in reducing growth of human eosinophil leukemia cells in a newly established xenograft model

Author keywords

[No Author keywords available]

Indexed keywords

FIP1L1 PROTEIN; IMATINIB; NILOTINIB; PDGFRA PROTEIN; PLACEBO; PROTEIN TYROSINE KINASE INHIBITOR; TUMOR MARKER; UNCLASSIFIED DRUG; 4 METHYL N (3 (4 METHYLIMIDAZOL 1 YL) 5 (TRIFLUOROMETHYL)PHENYL) 3 ((4 PYRIDIN 3 YLPYRIMIDIN 2 YL)AMINO)BENZAMIDE; 4-METHYL-N-(3-(4-METHYLIMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL)-3-((4-PYRIDIN-3-YLPYRIMIDIN-2-YL)AMINO)BENZAMIDE; ANTINEOPLASTIC AGENT; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE;

EID: 84856832061     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030567     Document Type: Article
Times cited : (3)

References (27)
  • 1
    • 67349151349 scopus 로고    scopus 로고
    • Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders
    • Valent P, (2009) Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders. Blood Rev 23: 157-165.
    • (2009) Blood Rev , vol.23 , pp. 157-165
    • Valent, P.1
  • 3
    • 77954143319 scopus 로고    scopus 로고
    • Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence
    • Crane MM, Chang CM, Kobayashi MG, Weller PF, (2010) Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol 126: 179-181.
    • (2010) J Allergy Clin Immunol , vol.126 , pp. 179-181
    • Crane, M.M.1    Chang, C.M.2    Kobayashi, M.G.3    Weller, P.F.4
  • 6
    • 75749119699 scopus 로고    scopus 로고
    • Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update
    • Tefferi A, Gotlib J, Pardanani A, (2010) Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update. Mayo Clin Proc 85: 158-164.
    • (2010) Mayo Clin Proc , vol.85 , pp. 158-164
    • Tefferi, A.1    Gotlib, J.2    Pardanani, A.3
  • 7
    • 0344987881 scopus 로고    scopus 로고
    • A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
    • Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, et al. (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348: 1201-1214.
    • (2003) N Engl J Med , vol.348 , pp. 1201-1214
    • Cools, J.1    DeAngelo, D.J.2    Gotlib, J.3    Stover, E.H.4    Legare, R.D.5
  • 8
    • 0022360099 scopus 로고
    • Establishment and characterization of a new human eosinophilic leukemia cell line
    • Saito H, Bourinbaiar A, Ginsburg M, Minato K, Ceresi E, et al. (1985) Establishment and characterization of a new human eosinophilic leukemia cell line. Blood 66: 1233-1240.
    • (1985) Blood , vol.66 , pp. 1233-1240
    • Saito, H.1    Bourinbaiar, A.2    Ginsburg, M.3    Minato, K.4    Ceresi, E.5
  • 9
    • 40949147830 scopus 로고    scopus 로고
    • A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients
    • Helbig G, Stella-Holowiecka B, Majewski M, Calbecka M, Gajkowska J, et al. (2008) A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients. Br J Haematol 141: 200-204.
    • (2008) Br J Haematol , vol.141 , pp. 200-204
    • Helbig, G.1    Stella-Holowiecka, B.2    Majewski, M.3    Calbecka, M.4    Gajkowska, J.5
  • 10
    • 1642324059 scopus 로고    scopus 로고
    • The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia
    • Cools J, Quentmeier H, Huntly BJ, Marynen P, Griffin JD, et al. (2004) The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood 103: 2802-2805.
    • (2004) Blood , vol.103 , pp. 2802-2805
    • Cools, J.1    Quentmeier, H.2    Huntly, B.J.3    Marynen, P.4    Griffin, J.D.5
  • 11
    • 46749115588 scopus 로고    scopus 로고
    • Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo
    • Nishioka C, Ikezoe T, Yang J, Miwa A, Tasaka T, et al. (2008) Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo. Blood 111: 5086-5092.
    • (2008) Blood , vol.111 , pp. 5086-5092
    • Nishioka, C.1    Ikezoe, T.2    Yang, J.3    Miwa, A.4    Tasaka, T.5
  • 12
    • 23844464445 scopus 로고    scopus 로고
    • Transplantation of human acute myeloid leukemia (AML) cells in immunodeficient mice reveals altered cell surface phenotypes and expression of human endothelial markers
    • Henschler R, Gottig S, Junghahn I, Bug G, Seifried E, et al. (2005) Transplantation of human acute myeloid leukemia (AML) cells in immunodeficient mice reveals altered cell surface phenotypes and expression of human endothelial markers. Leuk Res 29: 1191-1199.
    • (2005) Leuk Res , vol.29 , pp. 1191-1199
    • Henschler, R.1    Gottig, S.2    Junghahn, I.3    Bug, G.4    Seifried, E.5
  • 13
    • 0034544938 scopus 로고    scopus 로고
    • Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice
    • Flavell DJ, Warnes SL, Noss AL, Flavell SU, (2000) Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice. Br J Cancer 83: 1755-1761.
    • (2000) Br J Cancer , vol.83 , pp. 1755-1761
    • Flavell, D.J.1    Warnes, S.L.2    Noss, A.L.3    Flavell, S.U.4
  • 14
    • 77956649599 scopus 로고    scopus 로고
    • Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib
    • Manley PW, Stiefl N, Cowan-Jacob SW, Kaufman S, Mestan J, et al. (2010) Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib. Bioorg Med Chem 18: 6977-6986.
    • (2010) Bioorg Med Chem , vol.18 , pp. 6977-6986
    • Manley, P.W.1    Stiefl, N.2    Cowan-Jacob, S.W.3    Kaufman, S.4    Mestan, J.5
  • 15
    • 34548822673 scopus 로고    scopus 로고
    • AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo
    • Yang J, Ikezoe T, Nishioka C, Tasaka T, Taniguchi A, et al. (2007) AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. Blood 110: 2034-2040.
    • (2007) Blood , vol.110 , pp. 2034-2040
    • Yang, J.1    Ikezoe, T.2    Nishioka, C.3    Tasaka, T.4    Taniguchi, A.5
  • 16
    • 77953628107 scopus 로고    scopus 로고
    • Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib
    • Ikezoe T, Togitani K, Tasaka T, Nishioka C, Yokoyama A, (2010) Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib. Leuk Res 34: e200-201.
    • (2010) Leuk Res , vol.34
    • Ikezoe, T.1    Togitani, K.2    Tasaka, T.3    Nishioka, C.4    Yokoyama, A.5
  • 17
    • 66849087150 scopus 로고    scopus 로고
    • FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib
    • Lierman E, Michaux L, Beullens E, Pierre P, Marynen P, et al. (2009) FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib. Leukemia 23: 845-851.
    • (2009) Leukemia , vol.23 , pp. 845-851
    • Lierman, E.1    Michaux, L.2    Beullens, E.3    Pierre, P.4    Marynen, P.5
  • 18
    • 84856830328 scopus 로고    scopus 로고
    • Low-dose Nilotinib can maintain complete molecular remissions in FIP1L1/PDGFRA-positive hypereosinophilic syndrome
    • Tabouret E, Charbonnier A, Mozziconacci MJ, Ivanov V, (2010) Low-dose Nilotinib can maintain complete molecular remissions in FIP1L1/PDGFRA-positive hypereosinophilic syndrome. Leuk Res.
    • (2010) Leuk Res
    • Tabouret, E.1    Charbonnier, A.2    Mozziconacci, M.J.3    Ivanov, V.4
  • 19
    • 77953258448 scopus 로고    scopus 로고
    • Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript-results of Polish multicentre study
    • Helbig G, Moskwa A, Hus M, Piszcz J, Swiderska A, et al. (2009) Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript-results of Polish multicentre study. Hematol Oncol 28: 93-97.
    • (2009) Hematol Oncol , vol.28 , pp. 93-97
    • Helbig, G.1    Moskwa, A.2    Hus, M.3    Piszcz, J.4    Swiderska, A.5
  • 20
    • 0013879504 scopus 로고
    • Normal mouse erythropoiesis. I. The role of the spleen in mouse erythropoiesis
    • Brodsky I, Dennis LH, Kahn SB, Brady LW, (1966) Normal mouse erythropoiesis. I. The role of the spleen in mouse erythropoiesis. Cancer Res 26: 198-201.
    • (1966) Cancer Res , vol.26 , pp. 198-201
    • Brodsky, I.1    Dennis, L.H.2    Kahn, S.B.3    Brady, L.W.4
  • 21
    • 0032783222 scopus 로고    scopus 로고
    • The role of trisomy 8 in the pathogenesis of chronic eosinophilic leukemia
    • Ma SK, Kwong YL, Shek TW, Wan TS, Chow EY, et al. (1999) The role of trisomy 8 in the pathogenesis of chronic eosinophilic leukemia. Hum Pathol 30: 864-868.
    • (1999) Hum Pathol , vol.30 , pp. 864-868
    • Ma, S.K.1    Kwong, Y.L.2    Shek, T.W.3    Wan, T.S.4    Chow, E.Y.5
  • 22
    • 33845596263 scopus 로고    scopus 로고
    • Granulocytic sarcoma: 32 cases and review of the literature
    • Paydas S, Zorludemir S, Ergin M, (2006) Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma 47: 2527-2541.
    • (2006) Leuk Lymphoma , vol.47 , pp. 2527-2541
    • Paydas, S.1    Zorludemir, S.2    Ergin, M.3
  • 23
    • 0035191409 scopus 로고    scopus 로고
    • Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement
    • Park KU, Lee DS, Lee HS, Kim CJ, Cho HI, (2001) Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement. Am J Pathol 159: 2011-2016.
    • (2001) Am J Pathol , vol.159 , pp. 2011-2016
    • Park, K.U.1    Lee, D.S.2    Lee, H.S.3    Kim, C.J.4    Cho, H.I.5
  • 24
    • 56249123594 scopus 로고    scopus 로고
    • Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias
    • Gotlib J, Cools J, (2008) Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias. Leukemia 22: 1999-2010.
    • (2008) Leukemia , vol.22 , pp. 1999-2010
    • Gotlib, J.1    Cools, J.2
  • 25
    • 55949102355 scopus 로고    scopus 로고
    • Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study
    • Metzgeroth G, Walz C, Erben P, Popp H, Schmitt-Graeff A, et al. (2008) Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study. Br J Haematol 143: 707-715.
    • (2008) Br J Haematol , vol.143 , pp. 707-715
    • Metzgeroth, G.1    Walz, C.2    Erben, P.3    Popp, H.4    Schmitt-Graeff, A.5
  • 26
    • 77952812169 scopus 로고    scopus 로고
    • Guidelines for the welfare and use of animals in cancer research
    • Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, et al. (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102: 1555-1577.
    • (2010) Br J Cancer , vol.102 , pp. 1555-1577
    • Workman, P.1    Aboagye, E.O.2    Balkwill, F.3    Balmain, A.4    Bruder, G.5
  • 27
    • 33847235697 scopus 로고    scopus 로고
    • Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice
    • Thies A, Mauer S, Fodstad O, Schumacher U, (2007) Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice. Br J Cancer 96: 609-616.
    • (2007) Br J Cancer , vol.96 , pp. 609-616
    • Thies, A.1    Mauer, S.2    Fodstad, O.3    Schumacher, U.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.